Inventor · disambiguated record
Jonathan S. Wall
Also filed as: SALDANHA JOSE W · WALL JONATHAN · WALL JONATHAN S · WALL JONATHAN STUART
20 granted patents·17 pending applications·171 citations·filing 1999–2025
95Inventor score
Files withUNIV TENNESSEE RES FOUND11ATTRALUS INC7SCHENK DALE B4PROTHENA THERAPEUTICS LTD3UNIV TENNESSEE RES FOUNDATION3
Top patents by PatentIndex Score
37 records- 0197US7928203B2Chimeric, humanized, or human antibody 2A4ELAN PHARM INC·Filed 2008·Granted Apr 19, 2011·38 cites·3 claims
- 0293US12139529B2Antibody-peptide fusion proteins for treating amyloid disordersUNIV TENNESSEE RES FOUND·Filed 2023·Granted Nov 12, 2024·1 cites·9 claims
- 0393US12030934B2Modified immunoglobulins for targeting amyloid depositsATTRALUS INC·Filed 2023·Granted Jul 9, 2024·5 cites·30 claims
- 0493US2025268999A1Treatment and Prophylaxis of AmyloidosisPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 0591US12157765B2Modified immunoglobulins for targeting amyloid depositsATTRALUS INC·Filed 2024·Granted Dec 3, 2024·1 cites·29 claims
- 0691US10308685B2Inhibitory peptides of viral infectionUNIV TENNESSEE RES FOUND·Filed 2017·Granted Jun 4, 2019·6 cites·16 claims
- 0791US6423270B1Flow cytometric characterization of amyloid fibrilsUNIV TENNESSEE RES CORP·Filed 2001·Granted Jul 23, 2002·37 cites·25 claims
- 0890USRE47838EInhibitory peptides of viral infectionUNIV TENNESSEE RES FOUND·Filed 2018·Granted Feb 4, 2020·5 cites·20 claims
- 0990US10046050B2Targeting immunotherapy for amyloidosisUNIV TENNESSEE RES FOUND·Filed 2016·Granted Aug 14, 2018·10 cites·20 claims
- 1090US9683017B2Inhibitory peptides of viral infectionUNIV TENNESSEE RES FOUND·Filed 2015·Granted Jun 20, 2017·6 cites·20 claims
- 1190US8791243B2Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2008·Granted Jul 29, 2014·8 cites·17 claims
- 1290US8105594B2Methods for amyloid removal using anti-amyloid antibodiesSOLOMON ALAN·Filed 2010·Granted Jan 31, 2012·16 cites·14 claims
- 1388US8808666B2Peptides that specifically target amyloid depositsUNIV TENNESSEE RES FOUNDATION·Filed 2012·Granted Aug 19, 2014·6 cites·15 claims
- 1487US10213506B2Targeting immunotherapy for amyloidosisUNIV TENNESSEE RES FOUND·Filed 2015·Granted Feb 26, 2019·6 cites·16 claims
- 1586US12264195B2Modified immunoglobulins for targeting amyloid depositsATTRALUS INC·Filed 2024·Granted Apr 1, 2025·0 cites·24 claims
- 1681US10646568B2Targeting immunotherapy for amyloidosisUNIV OF TENESSEE RESEARCH FOUNDATION·Filed 2018·Granted May 12, 2020·2 cites·19 claims
- 1781US8636981B2Detection of amyloid deposits using anti-amyloid antibodiesSCHENK DALE B·Filed 2011·Granted Jan 28, 2014·2 cites·21 claims
- 1879US2025152667A1Sap fc fusion proteins and methods of useATTRALUS INC·Filed 2024·Application pending·0 cites
- 1976US2025101090A1Antibody-peptide fusion proteins for treating amyloid disordersUNIV TENNESSEE RES FOUND·Filed 2024·Application pending·0 cites
- 2073US2025368729A1Modified immunoglobulins for targeting amyloid depositsATTRALUS INC·Filed 2025·Application pending·0 cites
- 2172US12161692B2SAP FC fusion proteins and methods of useATTRALUS INC·Filed 2021·Granted Dec 10, 2024·0 cites·19 claims
- 2270US2021008185A1Treatment and Prophylaxis of AmyloidosisPROTHENA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2369US2022411489A1Modified immunoglobulins for targeting amyloid depositsATTRALUS INC·Filed 2020·Application pending·0 cites
- 2467US2014134103A1Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2013·Application pending·0 cites
- 2565US2018360934A1Treatment and prophylaxis of amyloidosisPROTHENA THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 2664US2012321555A1Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2012·Application pending·0 cites
- 2762US6245572B1Flow cytometric characterization of amyloid fibrilsUNIV TENNESSEE RES CORP·Filed 1999·Granted Jun 12, 2001·20 cites·26 claims
- 2860US7485616B2Methods of investigating, diagnosing, and treating amyloidosisUNIV TENNESSEE RES FOUNDATION·Filed 2001·Granted Feb 3, 2009·2 cites·19 claims
- 2960US2024216556A1Peptide-fc fusions for treating amyloid disordersUNIV TENNESSEE RES FOUND·Filed 2022·Application pending·0 cites
- 3059US2017081396A1Treatment and prophylaxis of amyloidosisPROTHENA THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 3156US2010061934A1Methods for diagnosis or treatment of amyloidosis by targeting hyper-sulfated proteoglycans present in amyloidWALL JONATHAN·Filed 2009·Application pending·0 cites
- 3255US2023068507A1Chimeric antigen receptors for removal of amyloidUNIV TENNESSEE RES FOUND·Filed 2021·Application pending·0 cites
- 3354US2024003912A1Method for diagnosing amyloid diseasesUNIV TENNESSEE RES FOUND·Filed 2021·Application pending·0 cites
- 3444US2009232733A1Diagnostic and Therapeutic Potential of Immune Globulin Intravenous (IGIV) ProductsO'NUALLAIN BRIAN·Filed 2006·Application pending·0 cites
- 3544US2009246191A1Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses ThereofUNIV TENNESSEE RES FOUNDATION·Filed 2008·Application pending·0 cites
- 3641US11293925B2Identifying amyloidogenic proteins and amyloidogenic riskUNIV TENNESSEE RES FOUND·Filed 2018·Granted Apr 5, 2022·0 cites·24 claims
- 3726US2003147882A1Methods for amyloid removal using anti-amyloid antibodiesFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan S. Wall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →